Pabst Labs is opening a new manufacturing facility and distribution center dedicated to cannabis beverages in Desert Hot Springs, California.
The "cutting edge” facility will allow the company to more than triple its production capabilities.
According to Chuck Barlick, Pabst Labs' director of production, the goal is to leverage over twenty years of beverage manufacturing experience while establishing a standard for quality and efficiency that would set the bar in all cannabis-infused beverages facilities.
On top of its eponymous Pabst Blue Ribbon 10mg High Seltzer, the company also produces Not Your Father's Cannabis-Infused Root Beer and the St. Ides Cannabis product line.
Other brands will be allowed to access the facility through co-packaging relationships to help raise beverage quality and opportunity across the industry.
THC-infused beverages are seeing a 40 percent growth rate, the fastest-growing category in the cannabis industry, according to the Cannabis Beverage Association (CBA).
PBR High Seltzer is one of the top-selling THC-infused carbonated beverages in California.


Middle East War Rattles Global Markets as Oil Tops $100 and Dollar Surges
Innate Pharma Reports 55% Revenue Drop and €49.2M Net Loss for 2025
Every generation thinks they had it the toughest, but for Gen Z, they’re probably right
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Merck's $6 Billion Bid for Terns Pharma Signals Bold Oncology Push
Iran Allows Oil Tankers Through Strait of Hormuz Amid U.S. Negotiations
Oil Prices Climb as Iran Reviews U.S. Peace Proposal Amid Middle East Tensions
CDC Acting Director Urges Measles Vaccination as U.S. Cases Surge in 2026
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
9 Tips for Avoiding Tax Season Cyber Scams
Columbia Student Mahmoud Khalil Fights Arrest as Deportation Case Moves to New Jersey
FDA Warns Novo Nordisk Over Misleading Ozempic Ad Claims
Meta Ties Executive Pay to Aggressive Stock Price Targets in Major Retention Push
Novocure Stock Surges 30% After FDA Approves Optune Pax for Pancreatic Cancer Treatment
Novo Nordisk Shares Tumble After CagriSema Misses Key Trial Endpoint
OpenAI Pulls the Plug on Sora, Ending $1 Billion Disney Partnership
AWS Bahrain Region Disrupted by Drone Activity Amid Middle East Conflict 



